Researchers conducted the multicenter trial in 21 hospitals located in seven countries — Belgium, Canada, England, Ireland, Italy, New Zealand and the Netherlands. The hospitals had continuous physician staffing and subspecialized pediatric services. Researchers enrolled patients from Feb. 28, 2011, through June 21, 2015. Follow-ups ended on July 19, 2015.
In total, 144,539 patients completed the trial, representing 559,443 patient-days. All-cause hospital mortality was 1.93 per 1,000 patient discharges at hospitals with a bedside pediatric early warning system. The all-cause death rate was 1.56 per 1,000 patient discharges at hospitals that provided usual care.
Additionally, the study shows significant clinical deterioration events occurred during 0.50 per 1,000 patient-days at hospitals with the bedside intervention as compared to 0.84 per 1,000 patient-days at hospitals with usual care.
More articles on healthcare quality:
Emails suggest state officials worked to put positive spin on Illinois VA Legionnaires’ outbreak: 5 things to know
Patient safety issues could drive $383B in healthcare costs by 2022
Why chance alone may identify HAC program’s low-performing hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
